ProPublica report : $ 300 million wasted on name-brand drugs . Taxpayers paid Hundreds of millions of dollars extra in eight-year thanks to more than a third practitioners , report says . Part D cost taxpayers $ 62 billion last year , and more than a third of that went toward this low-income subsidy ProPublica Part D has no incentive for low-income patients to demand generics , professor says .
ProPublica report : $ 300 million wasted on name-brand drugs . Taxpayers paid Hundreds of millions of dollars extra in eight-year thanks to more than a third practitioners , report says . ProPublica Part D has no incentive for low-income patients to demand generics , professor says .